Nikita Shah - SEC Form 4 Insider Trading Activity
Executive Vice President
Summary
Updated Aug 16, 2026
Nikita Shah has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $6.42M.
Profile
Nikita Shah is Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX). Shah has reported 6 insider filings with the SEC since 2025. The most recent filing was in March 2026.
- Role
- Executive Vice President
Board memberships
- Amneal Pharmaceuticals, Inc.
Trading Pattern
InsiderAlpha's records for Nikita Shah go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Nikita Shah has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX) - 7 filings, 2025 to 2026
Recent Transactions
18Companies - Last 90 Days
1- Amneal Pharmaceuticals, Inc. (AMRX) - 1 filing, last 2026-08-13
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Nikita Shah has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Jason B. Daly - $3.77M of AMRX open-market activity in the last 12 months
- Andrew S. Boyer - $2.62M of AMRX open-market activity in the last 12 months
- John Kiely - $1.18M of AMRX open-market activity in the last 12 months
- Ted C. Nark - $586K of AMRX open-market activity in the last 12 months
- Deborah M. Autor - $451K of AMRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Nikita Shah?
Nikita Shah is Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX). Shah has reported 6 insider filings with the SEC since 2025. The most recent filing was in March 2026.…
How many SEC Form 4 filings has Nikita Shah submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Nikita Shah been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($6.42M) across all tracked filings.
Where can I see all of Nikita Shah's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Get alerts when Nikita Shah files a new Form 4
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required